Oxford BioDynamics Plc

As of March 31, 2026, Oxford BioDynamics Plc carries a market capitalization of 823.85M, placing it among publicly traded companies globally. Its enterprise value stands at 1.00B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Oxford BioDynamics Plc's next confirmed earnings release is scheduled for January 26, 2027.

As of March 31, 2026, Oxford BioDynamics Plc has 4.29B shares outstanding.

These figures are as of March 31, 2026.

As of March 31, 2026, Oxford BioDynamics Plc maintains a current ratio of 2.01, meaning it holds 2.0x the short-term assets needed to cover near-term liabilities.

As of the close on October 23, 2026, Oxford BioDynamics Plc's stock has declined approximately 63.68% over the past 52 weeks. The 50-day moving average sits at 0.12, while the 200-day moving average is 0.18.

As of March 31, 2026, Oxford BioDynamics Plc holds 251.30M in cash and equivalents against 428.00M in total debt, resulting in a net debt position of -251.30M. Total book value stands at 325.20M, with working capital of 191.00M providing operational flexibility.